Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children
1 other identifier
observational
465
1 country
1
Brief Summary
This is a study to determine whether the Near infrared spectroscopy (NIRS) optical density (OD) measurement with an Infrascanner device accurately identifies the presence of an intracranial hematoma in pediatric patients ≤18 years of age after known or suspected traumatic brain injury compared with head computerized tomography (CT) scans as the gold standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2014
CompletedFirst Posted
Study publicly available on registry
May 29, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedNovember 7, 2018
November 1, 2018
4.3 years
May 20, 2014
November 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of NIRS Optical Density (OD) Measurement
Determine the sensitivity of the NIRS optical density measurement by the Infrascanner device for identifying the presence of intracranial hematomas in pediatric patients after known or suspected traumatic brain injury compared to head CT scans as the gold standard
2-years
Secondary Outcomes (3)
Specificity and Predictive Values of NIRS Measurement
2-years
Variability in Sensitivity and Specificity Based on Hematoma Characteristics
2-years
Age Varying Sensitivity
2-years
Study Arms (1)
Infrascanner exam
Infrascanner Model 2000 exams may be conducted either before or after an associated head CT for pediatric patients presenting to the emergency department (ED) or pediatric intensive care unit (PICU) with a known or suspected traumatic head injury undergoing a head CT scan to evaluate for the presence or absence of an intracranial hematoma. The time between the head CT scan and the Infrascanner exam will be within 6 hours. The exam involves placing a sensor on the designated areas of the head with the most common locations for traumatic hematoma. Readings from the monitor evaluating each region will be evaluated and recorded. The 8-point exam can be accomplished within 5 minutes or less.
Interventions
The Infrascanner Model 2000 device is a small, portable handheld device that uses near infrared (NIR) technology to screen patients for intracranial bleeding.
Eligibility Criteria
Emergency Department (ED), Pediatric Intensive Care Unit (PICU)
You may qualify if:
- Males or females ≤18 years admitted to the Children's Hospital of Philadelphia (CHOP) ED or PICU with a known or suspected traumatic head injury undergoing a head CT scan to evaluate for the presence of an intracranial hematoma.
- Head injury occurred \<12 hours prior to presentation for the initial CT scan, or the subject had a clinical change prompting repeat CT scanning.
You may not qualify if:
- Evidence of extensive scalp injury including lacerations, avulsions, or abrasions that will impair proper coupling of the Infrascanner device to the subject's head or prevent placement of the device in the specified locations.
- History of neurosurgical procedure (e.g. decompressive craniectomy) with residual bone flap.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Philadelphialead
- Boston Children's Hospitalcollaborator
- Children's Hospital Coloradocollaborator
Study Sites (1)
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Kirschen, MD, PhD
Children's Hospital of Philadelphia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2014
First Posted
May 29, 2014
Study Start
June 1, 2014
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
November 7, 2018
Record last verified: 2018-11